BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8056362)

  • 1. [Pelvic exenteration, morbidity and survival].
    Méndez L; Bernal A; Escudero P; González G; Fajardo A
    Ginecol Obstet Mex; 1994 Jun; 62():161-5. PubMed ID: 8056362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration, University of Michigan: 100 patients at 5 years.
    Morley GW; Hopkins MP; Lindenauer SM; Roberts JA
    Obstet Gynecol; 1989 Dec; 74(6):934-43. PubMed ID: 2586960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration for adenocarcinoma of the uterine cervix.
    Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
    Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration. Has it a role in 1987? A six year experience.
    Shepherd JH
    Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
    Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
    J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major morbidity after pelvic exenteration: a seven-year experience.
    Roberts WS; Cavanagh D; Bryson SC; Lyman GH; Hewitt S
    Obstet Gynecol; 1987 Apr; 69(4):617-21. PubMed ID: 3822305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].
    Kolbert G; Müller G; Kujath P; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1096-7. PubMed ID: 9574344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion.
    Uno T; Ito H; Isobe K; Kaneyasu Y; Tanaka N; Mitsuhashi A; Suzuka K; Yamazawa K; Shigematsu N; Itami J
    Gynecol Oncol; 2005 Feb; 96(2):335-40. PubMed ID: 15661218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration for carcinoma of the cervix.
    Ingersoll FM; Ulfelder H
    N Engl J Med; 1966 Mar; 274(12):648-51. PubMed ID: 17926376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
    Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
    Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
    Morris M; Alvarez RD; Kinney WK; Wilson TO
    Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
    Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pelvic exenteration for sarcomatous malignancies.
    Reid GC; Morley GW; Schmidt RW; Hopkins MP
    Obstet Gynecol; 1989 Jul; 74(1):80-4. PubMed ID: 2733946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic-assisted laparoscopic exenteration in recurrent cervical cancer Robotics improved the surgical experience for 2 women with recurrent cervical cancer.
    Davis MA; Adams S; Eun D; Lee D; Randall TC
    Am J Obstet Gynecol; 2010 Jun; 202(6):663.e1. PubMed ID: 20510970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
    Chiva LM; Lapuente F; Núñez C; Ramírez PT
    Gynecol Oncol; 2009 Apr; 113(1):47-51. PubMed ID: 19176235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic exenteration: a treatment for failed rectal cancer surgery.
    Estes NC; Thomas JH; Jewell WR; Beggs D; Hardin CA
    Am Surg; 1993 Jul; 59(7):420-2. PubMed ID: 8323074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of frequency and complications of pelvic exenterations for recurrent cervico-uterine cancer after radiation].
    Torres-Lobatón A; González-Mendoza RL; Román-Bassaure E; Hernández-Aten D; Rojo-Herrera G
    Ginecol Obstet Mex; 1996 Dec; 64():538-43. PubMed ID: 9019436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.